Skip to main content
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China flag China · Delayed Price · Currency is CNY
19.64
+0.16 (0.82%)
Apr 29, 2026, 3:00 PM CST

SHA:600671 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
2,3922,1081,0691,4201,1581,094
Upgrade
Market Cap Growth
70.63%97.15%-24.70%22.61%5.90%4.30%
Upgrade
Enterprise Value
2,5502,2981,1741,4511,2621,178
Upgrade
Last Close Price
19.6417.318.7811.669.518.98
Upgrade
PE Ratio
135.73119.6270.13---
Upgrade
PS Ratio
11.299.964.9211.6610.637.44
Upgrade
PB Ratio
25.4522.4312.5825.38254.0216.94
Upgrade
P/TBV Ratio
37.7433.2623.4147.77-30.09
Upgrade
P/OCF Ratio
202.84178.78----
Upgrade
EV/Sales Ratio
12.0410.855.4011.9211.598.01
Upgrade
EV/EBITDA Ratio
80.2372.6428.44---
Upgrade
EV/EBIT Ratio
148.55133.8439.88---
Upgrade
Debt / Equity Ratio
1.771.771.792.0525.451.76
Upgrade
Debt / EBITDA Ratio
5.235.233.17---
Upgrade
Net Debt / Equity Ratio
1.431.431.020.3016.161.42
Upgrade
Net Debt / EBITDA Ratio
4.254.252.10-1.47-2.54-4.67
Upgrade
Net Debt / FCF Ratio
-6.93-6.93-1.51-0.57-3.22-2.94
Upgrade
Asset Turnover
0.480.480.550.380.310.35
Upgrade
Inventory Turnover
2.422.422.452.171.881.78
Upgrade
Quick Ratio
0.640.640.580.620.340.51
Upgrade
Current Ratio
0.810.810.780.820.560.74
Upgrade
Return on Equity (ROE)
8.05%8.05%31.02%-129.89%-211.59%-41.52%
Upgrade
Return on Assets (ROA)
2.43%2.43%4.67%-4.33%-7.78%-4.32%
Upgrade
Return on Invested Capital (ROIC)
4.99%6.05%18.13%-29.84%-37.48%-16.44%
Upgrade
Return on Capital Employed (ROCE)
10.80%10.80%19.00%-17.90%-54.00%-19.30%
Upgrade
Earnings Yield
0.74%0.84%1.43%-2.70%-5.83%-2.73%
Upgrade
FCF Yield
-0.81%-0.92%-5.35%-2.07%-1.98%-2.85%
Upgrade
Payout Ratio
36.87%36.87%56.30%---
Upgrade
Buyback Yield / Dilution
-0.01%-0.01%0.01%0.00%1.92%-1.13%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.